|
|
1430 Decision Street
Vista, CA 92081 USA
phone:760-727-1280
fax:1-800-936-6569
|
|
| Symbol |
DJO |
| Exchange |
NYSE |
| Founded |
1978 |
| Employees |
1300 |
|
|
| www.djortho.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Products and services that rehabilitate soft tissue and bone. |
|
| Management |
| Leslie H. Cross, Chief Executive Officer; Vickie L. Capps, Executive Vice President and Chief Financial Officer and Treasurer; Luke T. Faulstick, Executive Vice President and Chief Operating Officer; Donald M. Roberts, Executive Vice President, General Counsel and Secretary; Tom Capizzi, Executive Vice President, Global Human Resources |
| |
|
|
|
|
|
|
| Recent Results |
| On October 9, 2003, dj Orthopedics signed a definitive agreement to purchase the bone growth stimulation business from OrthoLogic Corporation for $93 million in cash. OrthoLogic has established a successful bone growth stimulation business with state-of-the-art technology, superior competitive benefits and growing market share. The acquisition has the potential to add significant value to the financial profile of dj Orthopedics. The transaction is expected to be completed before the end of the year 2003. |
| |
|
|
|
|
| Keywords |
| reconstruction, orthopedics, advamed |
|
|
|
| Description |
|
DJO, Inc (formerly dj Orthopedics) is a global orthopedic sports medicine company specializing in the design, manufacture and marketing of products and services that rehabilitate soft tissue and bone, help protect against injury and treat osteoarthritis of the knee. Its broad range of over 600 existing products, many of which are based on proprietary technologies, includes rigid knee braces, soft goods, specialty and other complementary orthopedic products. These products provide solutions for patients and orthopedic sports medicine professionals throughout the patient's continuum of care. |
|
| Products / Services |
The company's range of 600 rehabilitation products includes rigid knee braces, soft goods, cold therapy, and pain management systems. dj Orthopaedics recently acquired the bone growth stimulation device business from OrthoLogic Corporation, which develops, manufactures, and markets orthopedic products designed to promote the healing of musculoskeletal bone and tissue through electromagnetic field technology. The company's regeneration products consist of two bone grown stimulation devices - the OL 1000 and SpinaLogic. The OL 1000 utilizes a patented Combined Magnetic Field technology to deliver a highly specific, low-energy signal for the noninvasive treatment of an established nonunion fracture acquired secondary to trauma.
|
|
| Market / Customers |
The bone growth stimulation market is one of the fastest growing segments of the nearly $4 billion orthopedic sports medicine on the market.
|
|
| Competitors / Substitutes / Alternatives |
Biomet Inc (BMET), Zimmer Holdings Inc (ZMH), DePuy Inc.
|
|
| Strategy |
The strategic objectives are to strengthen leadership in the orthopedic sports medicine market and to increase revenues and achieve profitability. The key elements of the business strategy include: emphasis in rehabilitation and increased attention to developing and marketing new and innovative rehabilitation products, as well as increasing market share for existing products. Using materials, process and design expertise in bracing and supports, the Company will continue to enhance its current range of products to address changing customer needs, emphasizing high quality product designs that will reduce labor and material costs.
|
|
|
|
| |
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
